Status: Recruiting

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

Participants needed: 40

Trial details

Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Oui Therapeutics, Inc.Updated: Jan 5, 2026Locations: 1

Eligibility criteria

Posttraumatic stress disorder (PTSD) diagnosis [+4]

Score of 24 or lower on the ASI-3 [+6]

Status: Not yet recruiting

Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

Participants needed: 40

Trial details

Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Oui Therapeutics, Inc.Updated: Jun 19, 2025

Eligibility criteria

Posttraumatic stress disorder (PTSD) diagnosis [+4]

Score of 24 or lower on the ASI-3 [+6]

Status: Not yet recruiting

The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.

Participants needed: 30

Trial details

Age: 18-70Biological sex: AllType: InterventionalSponsor: Oui Therapeutics, Inc.Updated: Jun 12, 2024

Eligibility criteria

English speaking male or female patients, 18-70 years [+5]

Patients with active psychosis [+4]